Aridis Pharmaceuticals, Inc.
(NASDAQ : ARDS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.18%152.820.7%$1192.74m
PFEPfizer Inc. -0.13%34.350.9%$1183.78m
MRKMerck & Co., Inc. -1.49%72.210.7%$851.60m
BMYBristol-Myers Squibb Co. -1.98%59.551.0%$796.09m
ABBVAbbVie, Inc. -0.77%105.891.9%$740.37m
LLYEli Lilly & Co. -0.73%200.531.1%$642.58m
AZNAstraZeneca Plc -0.36%46.991.2%$495.38m
GSKGlaxoSmithKline Plc -0.35%34.120.2%$282.66m
NVSNovartis AG -0.96%83.370.2%$165.52m
SNYSanofi 0.40%45.640.2%$156.76m
VTRSViatris, Inc. -2.45%13.540.0%$148.10m
VERUVeru, Inc. -8.37%12.050.0%$100.23m
NVONovo Nordisk A/S -2.91%69.380.1%$84.67m
KALVKalVista Pharmaceuticals, Inc. -3.23%31.150.4%$81.04m
RPRXRoyalty Pharma Plc -3.57%42.020.2%$79.92m

Company Profile

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in Los Gatos, CA.